News

Neurocrine Biosciences Surges with 28% Growth in Revenue

Neurocrine Biosciences Surges with 28% Growth in Revenue

Neurocrine Biosciences Reports Remarkable Growth in Q3 2025

Achieved Total Net Product Sales of $790 Million Representing 28% Year-Over-Year Growth

INGREZZA (valbenazine) Third-Quarter 2025 Net Product Sales of $687 Million Representing 12% Year-Over-Year Growth

CRENESSITY (crinecerfont) Third-Quarter 2025 Net Product Sales of $98 Million with 540 Total New Patient Enrollment Start Forms

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has announced an impressive performance for the third quarter of 2025, marking a substantial increase in total net product sales and further proving its strong impact in the neuroscience market. This achievement highlights the effectiveness of the company’s product portfolio and its commitment to advancing patient care.

Financial Highlights

The company recorded total net product sales of $790 million for Q3 2025, representing a 28% increase from the same quarter last year. This includes revenues from both INGREZZA and CRENESSITY, which continued to show robust demand and growth.

INGREZZA Growth

INGREZZA, used for the treatment of tardive dyskinesia, generated $687 million in net product sales this quarter. This reflects a significant 12% year-over-year increase, driven by strong patient demand and an uptick in new patient prescriptions.

CRENESSITY Launch Success

CRENESSITY contributed $98 million to the revenue, marking strong early demand with 540 new patient starts enrolled. This product, viewed as a first-in-class therapy for patients with classic congenital adrenal hyperplasia, is making a substantial impact in the market.

CEO Statement on Momentum

"Neurocrine's third quarter commercial results highlight the meaningful impact that INGREZZA and CRENESSITY are having on patients' lives," said Kyle W. Gano, Ph.D., Chief Executive Officer of Neurocrine Biosciences. "Our ongoing clinical trials for potential treatments for major depressive disorder and schizophrenia further position us for leadership in neuroscience innovation, advancing transformative therapies that can significantly improve patient outcomes."

Upcoming Developments

Neurocrine has initiated a second Phase 3 clinical trial for direclidine, investigating its efficacy in treating schizophrenia. The company has also been honored for presenting pivotal data from the Phase 2 SAVITRI trial regarding osavampator’s effects on depression severity.

Financial Outlook

Despite the operational and commercial successes, the company is looking ahead with continued investments in research and development. There has been an expanded investment in creating a solid base for its clinical portfolio. The outlook remains positive with expected revenue guidance reflecting ongoing support for INGREZZA and the recent launch of CRENESSITY.

Invitation for Investors

Neurocrine Biosciences will host its R&D Day, providing investors with insights into the ongoing research initiatives, pipeline advancements, and broader business strategies aimed at enhancing shareholder value.

Frequently Asked Questions

What was Neurocrine's total net product sales for Q3 2025?

Neurocrine reported total net product sales of $790 million for the third quarter of 2025.

How much did INGREZZA sell in the third quarter of 2025?

INGREZZA achieved net product sales of $687 million, a 12% increase compared to Q3 of the previous year.

What are the main drivers of growth for CRENESSITY?

The strong demand for CRENESSITY in treating classic congenital adrenal hyperplasia drove its net product sales to $98 million, with a significant number of new patients enrolled.

What future clinical initiatives is Neurocrine pursuing?

Neurocrine has initiated a second Phase 3 clinical trial for direclidine as a potential treatment for schizophrenia.

When will Neurocrine host its R&D Day?

Neurocrine's R&D Day will be held at the company’s headquarters, showcasing their leading innovations and future therapeutic endeavors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Technical Deep Dive into HONOR X9e Pro's Durability

Updated Category News Views 56

Rethinking Smartphone Power HONOR's latest device, the X9e Pro, flaunts an 11,000mAh battery—stuck it right behind a neat cover without making the thing feel like a brick. You'd think with a battery that big, they’d have to hire bodybuilders to lift it, but nope. At 8.08mm thick and weighing just 203g, this phone bucks the bulk. They’ve squeezed the power of a power...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Ryde Group Faces Class Action: Key Investor Takeaways

Updated Category News Views 51

Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...

Continue Reading
Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 96

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 109

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 37

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
BAIC FOTON Builds Service Hub in South Africa

Updated Category News Views 28

There's something about seeing a company go all-in on a continent like Africa. This time, it's BAIC FOTON, putting down roots in South Africa with a spanking new training center. On October 27, just before their Africa Partners Conference, they opened up the BAIC FOTON Africa Regional Training Center. This move isn't just about bricks and mortar—it's about creating a...

Continue Reading
Raleigh's Auction Direct Stresses Oil Changes

Updated Category News Views 50

Keeping Engines Humming in Raleigh There's nothing quite like keeping an engine running like clockwork, especially in a place like Raleigh where folks rely on their rides day in and day out. That's where Auction Direct USA steps in, offering professional oil change services aimed at preserving the performance and reliability of used cars. A simple yet crucial service:...

Continue Reading
Elbit Systems Poised for Q3 2026 Earnings Reveal

Updated Category News Views 84

Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...

Continue Reading
Quarterra Taps Jeb Cox for Texas Development Leadership

Updated Category News Views 70

Big Moves in the Lone Star State Jeb Cox is stepping into some rather big cowboy boots over at Quarterra. With nearly two decades under his belt in the multifamily game, he's saddling up as the new Managing Director of Development in Texas. Quarterra, no stranger to the multifamily rodeo, wants to tighten its grip on the bustling Texas market. And Cox, with his gritty,...

Continue Reading

Top 5 Most Recently Viewed Articles

Workplace Safety Sector Expected to Reach $38.55 Billion by 2030

Updated Category News Views 138

Introduction to Workplace Safety Market Growth The global Workplace Safety Market is on a remarkable trajectory, expected to expand from USD 19.64 billion in 2025 to USD 38.55 billion by 2030. This signifies an impressive compound annual growth rate (CAGR) of 14.4%. With businesses increasingly prioritizing safety and compliance, this growth reflects not just numbers but...

Continue Reading
YinzCam Launches Innovative Basketball App in the UAE Market

Updated Category News Views 136

YinzCam Expands to the UAE with New Mobile Application PITTSBURGH and DUBAI, UAE — YinzCam, an industry leader in mobile app development, is making waves by launching its first mobile app in the United Arab Emirates. This application, created in partnership with Dubai Basketball, represents a significant milestone as the franchise enters the EuroLeague and Adriatic...

Continue Reading
Jet Linx Unveils Free In-Flight WiFi for Jet Card Members

Updated Category News Views 149

Jet Linx Enhances Connectivity for Jet Card Members Jet Linx, a leading provider in the private aviation sector, has recently made a significant enhancement to its Jet Card offerings by introducing complimentary in-flight WiFi on Super Midsize and Heavy Jet flights. This new feature marks a noteworthy commitment to improving the travel experience for its Jet Card Members....

Continue Reading
Urgent Message From Lawyer About Spain's Tax Compliance Issues

Updated Category News Views 247

Urgent Call to Address Spain's Tax Practices International lawyer Robert Amsterdam stands ready to take action regarding alarming tax practices in Spain that could have profound implications for U.S. investors and businesses. His firm, Amsterdam & Partners LLP, is set to unveil a critical white paper titled "Hacienda vs. The People," which delves into the troubling...

Continue Reading
Growth Potential and Strategic Shifts at Duckhorn Portfolio

Updated Category News Views 173

Strategic Overview of Duckhorn Portfolio The Duckhorn Portfolio, Inc. (NYSE: NAPA), a distinguished name in the luxury wine sector, has garnered major attention recently owing to its acquisition by Butterfly Equity. While this exciting development unfolds, the company is also managing various market challenges that necessitate a thorough exploration of NAPA's current...

Continue Reading